Biotech startup Vaccitech which co-invented covid-19 vaccine AstraZeneca is going public at a $613mn valuation
Vaccitech, the company behind the Covid-19 vaccine platform developed by AstraZeneca and the University of Oxford, announced this Monday that it plans to raise $117 million with the initial public offering (IPO) in the US, in an operation that would value the company at $613